Views & Analysis AI chatbots step up to help fight COVID-19 The COVID-19 pandemic has placed enormous stress on both healthcare systems and researchers, and people all across the sector are looking for digital solutions to help ease the pressure.
Views & Analysis Coronavirus pharma news roundup - 03/07/20 Now that coronavirus drugs have been approved, market access looks set to be the next major challenge.
Views & Analysis Unlocking the healing power of music Continuing our series on how digital health is fighting back against COVID
Views & Analysis How necessity is driving the ‘inevitable transformation’ of ... From virtual conferences to CPD webinars, medical education moved online when COVID-19 hit. But is this new way of learning here to stay?
Views & Analysis Coronavirus pharma news roundup - 26/06/20 As COVID-19 drugs vie for approval, we highlight the top pharma R&D, digital and market access news for coronavirus from the past week.
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.